QuidelOrtho Corp (QDEL)

Nasdaq Pharmaceutical Diagnostics SIC: 2835
D
Pipeline Grade

Financial Position (from SEC Filings)

$140.4M
Cash & Equivalents
$33.0M
Quarterly Burn Rate
13 mo
Est. Cash Runway
$841M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06853626 One-hoUr Troponin Using a High-sensitivity Point-Of-Care Assay in Emergency Primary Care OTHER Recruiting 2,500

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for QDEL.

SEC EDGAR Filings

All SEC filings for QuidelOrtho Corp on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.